Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
5,590.00
-20.00 (-0.36%)
At close: Sep 11, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 78.46 billion as of September 11, 2026. Its market cap has decreased by -19.80% in one year.
Market Cap
78.46B
Enterprise Value
141.79B
Revenue
211.48B
Ranking
n/a
PE Ratio
3.28
Stock Price
5,590.00
ChartMarket Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 78.46B, an increase of 502.04%. That is a compound annual growth rate of 7.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 78.46B | -14.92% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 85.49B |
| Sam-A Pharm. | 85.14B |
| KOREA PHARMA | 83.11B |
| Samik Pharmaceutical Company LTD. | 79.63B |
| BL Pharmtech | 75.91B |
| GL Pharm Tech | 72.66B |
| Polaris AI Pharma | 72.53B |
| Pharos iBio | 71.46B |